EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Global practice patterns of MR-linac use in head and neck radiotherapy: a survey by the international MR-Linac consortium

Colin Belliveau, Christian Rønn Hansen, Chris Terhaard, Mischa de Ridder, Houda Bahig, Paul Renz, Gabriel Alejandro Contreras Palafox, Muhammad Atif Mansha, Daniel Xing, Tivanka Senanayake, Ruta Zukauskaite, Camilla Kjaer Lonkvist und 10 weitere

Clinical and Translational Radiation Oncology · 2027-01 · 62 · 101347

DOI: 10.1016/j.ctro.2026.101347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Radiation Oncology, 2027-01. Verfasst von Colin Belliveau und 21 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Canada. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head-and-neck (HN) cancers remain prevalent, and most patients require radiotherapy as part of their treatment. Anatomical changes during treatment can alter dose distribution, potentially impacting both tumor control and toxicity. Magnetic resonance-guided linear accelerators (MR-Linacs) enable adaptive radiotherapy by integrating high-resolution soft-tissue imaging with on-table plan adaptation. However, global practice patterns, expert priorities, and barriers to implementation of this emerging technology remain incompletely characterized. We therefore conducted a survey to evaluate perceived benefits and barriers to MR-guided radiotherapy in head-and-neck cancers.

Methods

A cross-sectional survey was distributed to experts within the Head and Neck MR-Linac Consortium, assessing five domains: current clinical use, treatment delivery approaches, automation, re-irradiation practices, and clinical trial priorities.

Results

Thirty-six experts from four continents responded (67%, n = 24/36 from academic centers). Although 86% (n = 31/36) reported access to MR-Linac technology, only 28% (n = 10/36) treated HN patients, with a median of 2.5 patients treated per respondent (IQR 1-20). Adaptive strategies varied, including adapt-to-position (40%, n = 4/10), online adapt-to-shape (40%, n = 4/10), and offline adapt-to-shape (20%, n = 2/10). Reported barriers included prolonged treatment times, limited staffing resources, and suboptimal plan quality. Key priorities for improvement included volumetric modulated arc therapy (VMAT) implementation, faster dose delivery, AI-assisted auto-contouring, and standardized quality assurance workflows. Functional imaging, particularly diffusion-weighted imaging, and dose accumulation reporting were also highly valued. For future clinical trials, early identification of responders was considered essential, weekly adapt-to-shape workflows were deemed feasible, and stereotactic body radiotherapy (SBRT) was preferred for re-irradiation. Cost-effectiveness analyses were consistently highlighted as important.

Conclusions

This international survey of MR-Linac practice in head-and-neck cancer demonstrates substantial interest in the technology but limited clinical uptake, largely due to workflow inefficiencies and heterogeneous adaptive strategies. Advances in treatment delivery efficiency, AI-driven automation, standardized quality assurance, and dose accumulation methodologies will be essential to support broader clinical integration and to guide future trial design.

Schlagwörter

Stichwörter der Autor:innen

AdaptiveHead and NeckMR-linacMRIcanceroncologyprecision

Autor:innen und Institutionen

  • Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Canada.
  • Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Radiation Oncology Department, UMC, Utrecht, the Netherlands.
  • Allegheny Health Network, USA.

Zitieren

APA

Belliveau, C., Hansen, C. R., Terhaard, C., de Ridder, M., Bahig, H., Renz, P., Palafox, G. A. C., Mansha, M. A., Xing, D., Senanayake, T., Zukauskaite, R., Lonkvist, C. K., Filion, E., Boeke, S., Thorwarth, D., di Monale, M. B., Bastia, Wong, K., Castelli, J., …, & Ng, S. P. (2027). Global practice patterns of MR-linac use in head and neck radiotherapy: a survey by the international MR-Linac consortium. Clinical and Translational Radiation Oncology, 62, 101347. https://doi.org/10.1016/j.ctro.2026.101347

Vancouver

Belliveau C, Hansen CR, Terhaard C, de Ridder M, Bahig H, Renz P, et al. Global practice patterns of MR-linac use in head and neck radiotherapy: a survey by the international MR-Linac consortium. Clinical and Translational Radiation Oncology. 2027;62:101347. doi:10.1016/j.ctro.2026.101347

BibTeX
@article{Belliveau2027,
  author = {Belliveau, Colin and Hansen, Christian Rønn and Terhaard, Chris and de Ridder, Mischa and Bahig, Houda and Renz, Paul and Palafox, Gabriel Alejandro Contreras and Mansha, Muhammad Atif and Xing, Daniel and Senanayake, Tivanka and Zukauskaite, Ruta and Lonkvist, Camilla Kjaer and Filion, Edith and Boeke, Simon and Thorwarth, Daniela and di Monale, Michela Buglione and Bastia and Wong, Kee and Castelli, Joël and Fuller, Clifton D and Moreno, Amy and Ng, Sweet Ping},
  title = {Global practice patterns of MR-linac use in head and neck radiotherapy: a survey by the international MR-Linac consortium},
  journal = {Clinical and Translational Radiation Oncology},
  year = {2027},
  volume = {62},
  pages = {101347},
  doi = {10.1016/j.ctro.2026.101347}
}
Kostenlos starten →